Clin2
NCT05576038Possibly a fitRecruiting

Tryptophan to help celiac symptoms improve

Tryptophan Metabolism AlterationsCeliac Disease

Part of Digestive system, Hormones & metabolism clinical trials.

This trial tests whether tryptophan (a natural amino acid) can improve symptoms in people with celiac disease who still have symptoms despite following a gluten-free diet. It may help by supporting an internal body signal pathway researchers believe is impaired in some people with celiac disease.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old
  • You have celiac disease confirmed by a past biopsy and blood test (anti-tTG IgA)
  • You still have significant celiac-related symptoms after more than 1 year on a gluten-free diet
  • You have not taken antibiotics or probiotics in the last 8 weeks
  • You are not taking acid-reducing medicines (anti-secretory meds/antacids) during the study
  • You do not have certain other gut/autoimmune conditions, food intolerances (lactose/fructose), or past stomach surgery

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06982963Recruiting· Phase 2
Study of an experimental drug for celiac disease

This study tests an experimental medication for adults with celiac disease to see if it can protect against gluten exposure. You will need to follow a gluten-free diet and undergo a short, planned gluten challenge.

Melbourne
NCT07298343Recruiting· Phase 2
Testing ZED1227 for non-responsive celiac disease

This trial tests a new medicine, ZED1227, for people with celiac disease who still have symptoms despite eating gluten-free. The goal is to see if it helps reduce those symptoms.

Mainz
NCT07377565Recruiting· Phase 1
Testing a new diagnostic for celiac disease during endoscopy

This study tests a new medicine called HB-2121 used as a diagnostic tool during an upper endoscopy to help improve detection of celiac disease. It's designed for people who are already scheduled for this procedure and may help doctors see the gut damage caused by celiac more clearly.

Stanford, California
NCT07585669Recruiting
Omega-3 Supplements for New Celiac Disease Patients

This study tests whether omega-3 fatty acids (a type of fish oil supplement) can reduce inflammation and improve gut health in people newly diagnosed with celiac disease. Participants will follow a gluten-free diet while taking the supplement to see if it helps their body heal.

Santiago, Metropolitan Region
NCT07039773Recruiting
Gluten challenge in celiac disease: finding the best gluten type

This trial compares different forms of gluten to see which one causes the strongest immune reaction in people with celiac disease. It may help doctors choose the best way to test gluten sensitivity in the future.

Oslo, Oslo
NCT06059716Recruiting
Gluten detection and education for new celiac diagnosis

This study helps people newly diagnosed with celiac disease learn to use a gluten-detection device and get education to better manage their diet and health.

Chicago, Illinois

Hear when a new Celiac Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.